{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:24:43Z","timestamp":1792185883743,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000270","name":"Natural Environment Research Council","doi-asserted-by":"publisher","award":["165232"],"award-info":[{"award-number":["165232"]}],"id":[{"id":"10.13039\/501100000270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Sci Pollut Res"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11356-018-3834-9","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:59:58Z","timestamp":1543885198000},"page":"3479-3491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Comparison of Prioritisation Schemes for Human Pharmaceuticals in the Aquatic Environment"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6211-8918","authenticated-orcid":false,"given":"Sarah","family":"Letsinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"3834_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2166\/wst.2008.816","volume":"57","author":"NE Adler","year":"2008","unstructured":"Adler NE, Koschorreck J, Rechenberg B (2008) Environmental impact assessment and control of pharmaceuticals: the role of environmental agencies. Water Sci Technol 57:91\u201397. \n                    https:\/\/doi.org\/10.2166\/wst.2008.816","journal-title":"Water Sci Technol"},{"key":"3834_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jhazmat.2016.05.065","volume":"317","author":"OSA Al-Khazrajy","year":"2016","unstructured":"Al-Khazrajy OSA, Boxall ABA (2016) Impacts of compound properties and sediment characteristics on the sorption behaviour of pharmaceuticals in aquatic systems. J Hazard Mater 317:198\u2013209. \n                    https:\/\/doi.org\/10.1016\/j.jhazmat.2016.05.065","journal-title":"J Hazard Mater"},{"key":"3834_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.scitotenv.2004.04.062","volume":"333","author":"D Ashton","year":"2004","unstructured":"Ashton D, Hilton M, Thomas KV (2004) Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333:167\u2013184. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2004.04.062","journal-title":"Sci Total Environ"},{"key":"3834_CR4","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1021\/es2034125","volume":"46","author":"T Backhaus","year":"2012","unstructured":"Backhaus T, Faust M (2012) Predictive environmental risk assessment of chemical mixtures: a conceptual framework. Environ Sci Technol 46:2564\u20132573. \n                    https:\/\/doi.org\/10.1021\/es2034125","journal-title":"Environ Sci Technol"},{"key":"3834_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.scitotenv.2013.03.043","volume":"454\u2013455","author":"DR Baker","year":"2013","unstructured":"Baker DR, Kasprzyk-Hordern B (2013) Spatial and temporal occurrence of pharmaceuticals and illicit drugs in the aqueous environment and during wastewater treatment: new developments. Sci Total Environ 454\u2013455:442\u2013456. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2013.03.043","journal-title":"Sci Total Environ"},{"key":"3834_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.toxlet.2007.10.012","volume":"176","author":"JP Besse","year":"2008","unstructured":"Besse JP, Garric J (2008) Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. Toxicol Lett 176:104\u2013123. \n                    https:\/\/doi.org\/10.1016\/j.toxlet.2007.10.012","journal-title":"Toxicol Lett"},{"key":"3834_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/10807030802235078","volume":"14","author":"JP Besse","year":"2008","unstructured":"Besse JP, Kausch-Barreto C, Garric J (2008) Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: application to the French situation and preliminary prioritization. Hum Ecol Risk Assess 14:665\u2013695. \n                    https:\/\/doi.org\/10.1080\/10807030802235078","journal-title":"Hum Ecol Risk Assess"},{"key":"3834_CR8","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.watres.2006.05.036","volume":"40","author":"JP Bound","year":"2006","unstructured":"Bound JP, Voulvoulis N (2006) Predicted and measured concentrations for selected pharmaceuticals in UK rivers: implications for risk assessment. Water Res 40:2885\u20132892. \n                    https:\/\/doi.org\/10.1016\/j.watres.2006.05.036","journal-title":"Water Res"},{"key":"3834_CR9","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1002\/etc.3842","volume":"36","author":"EE Burns","year":"2017","unstructured":"Burns EE, Thomas-Oates J, Kolpin DW, Furlong ET, Boxall AB (2017) Are exposure predictions, used for the prioritization of pharmaceuticals in the environment, fit for purpose? Environ Toxicol Chem 36:2823\u20132832. \n                    https:\/\/doi.org\/10.1002\/etc.3842","journal-title":"Environ Toxicol Chem"},{"key":"3834_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.watres.2018.02.066","volume":"137","author":"EE Burns","year":"2018","unstructured":"Burns EE, Carter LJ, Kolpin DW, Thomas-Oates J, Boxall ABA (2018a) Temporal and spatial variation in pharmaceutical concentrations in an urban river system. Water Res 137:72\u201385. \n                    https:\/\/doi.org\/10.1016\/j.watres.2018.02.066","journal-title":"Water Res"},{"issue":"3","key":"3834_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/10937404.2018.1465873","volume":"21","author":"EE Burns","year":"2018","unstructured":"Burns EE, Carter LJ, Snape JR, Thomas-Oates J, Boxall ABA (2018b) Application of prioritization approaches to optimize environmental monitoring and testing of pharmaceuticals. J Toxicol Environ Health B Crit Rev 21(3):115\u2013141. \n                    https:\/\/doi.org\/10.1080\/10937404.1465873","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"3834_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.toxlet.2005.10.023","volume":"163","author":"AC Capleton","year":"2006","unstructured":"Capleton AC, Courage C, Rumsby P, Holmes P, Stutt E, Boxall ABA, Levy LS (2006) Prioritising veterinary medicines according to their potential indirect human exposure and toxicity profile. Toxicol Lett 163:213\u2013223. \n                    https:\/\/doi.org\/10.1016\/j.toxlet.2005.10.023","journal-title":"Toxicol Lett"},{"key":"3834_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.yrtph.2012.07.003","volume":"65","author":"Z Dong","year":"2013","unstructured":"Dong Z, Senn DB, Moran RE, Shine JP (2013) Prioritizing environmental risk of prescription pharmaceuticals. Regul Toxicol Pharmacol 65:60\u201367. \n                    https:\/\/doi.org\/10.1016\/j.yrtph.2012.07.003","journal-title":"Regul Toxicol Pharmacol"},{"key":"3834_CR14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/etc.3165","volume":"35","author":"RL Donnachie","year":"2016","unstructured":"Donnachie RL, Johnson AC, Sumpter JP (2016) A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals. Environ Toxicol Chem 35:1021\u20131027. \n                    https:\/\/doi.org\/10.1002\/etc.3165","journal-title":"Environ Toxicol Chem"},{"key":"3834_CR15","unstructured":"EMEA (2006) Guideline on the environmental risk assessment of medicinal products for human use. Available from: \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/10\/WC500003978.pdf\n                    \n                  . Accessed 17 May 2018"},{"key":"3834_CR16","unstructured":"EU (2003) Environmental risk assessment for human medicinal products containing or consisting of GMOs, III\/5504\/94 draft 4. Available from: \n                    https:\/\/echa.europa.eu\/documents\/10162\/16960216\/tgdpart2_2ed_en.pdf\n                    \n                  . Accessed 17 May 2018"},{"key":"3834_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/etc.3131","volume":"35","author":"E Fabbri","year":"2016","unstructured":"Fabbri E, Franzellitti S (2016) Human pharmaceuticals in the marine environment: focus on exposure and biological effects in animal species. Environ Toxicol Chem 35:799\u2013812. \n                    https:\/\/doi.org\/10.1002\/etc.3131","journal-title":"Environ Toxicol Chem"},{"key":"3834_CR18","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1897\/03-246","volume":"23","author":"B Ferrari","year":"2004","unstructured":"Ferrari B, Mons R, Vollat B, Fraysse B, Pax\u00e9us N, Lo Giudice R, Pollio A, Garric J (2004) Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23:1344\u20131354. \n                    https:\/\/doi.org\/10.1897\/03-246","journal-title":"Environ Toxicol Chem"},{"key":"3834_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.yrtph.2010.08.025","volume":"58","author":"J Fick","year":"2010","unstructured":"Fick J, Lindberg RH, Tysklind M, Larsson DGJ (2010) Predicted critical environmental concentrations for 500 pharmaceuticals. Regul Toxicol Pharmacol 58:516\u2013523. \n                    https:\/\/doi.org\/10.1016\/j.yrtph.2010.08.025","journal-title":"Regul Toxicol Pharmacol"},{"key":"3834_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jhazmat.2015.08.019","volume":"300","author":"J Garc\u00eda-Cambero","year":"2015","unstructured":"Garc\u00eda-Cambero J, Garc\u00eda-Cort\u00e9s H, Valc\u00e1rcel Y, Catal\u00e1 M (2015) Environmental concentrations of the cocaine metabolite benzoylecgonine induced sublethal toxicity in the development of plants but not in a zebrafish embryo\u2013larval model. J Hazard Mater 300:866\u2013872. \n                    https:\/\/doi.org\/10.1016\/j.jhazmat.2015.08.019","journal-title":"J Hazard Mater"},{"issue":"1656","key":"3834_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1098\/rstb.2013.0572","volume":"369","author":"S Gaw","year":"2014","unstructured":"Gaw S, Thomas KV, Hutchinson TH (2014) Sources, impacts and trends of pharmaceuticals in the marine and coastal environment. Philos Trans R Soc Lond Ser B Biol Sci 369(1656):1\u201311. \n                    https:\/\/doi.org\/10.1098\/rstb.2013.0572","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"3834_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.chemosphere.2014.03.132","volume":"111","author":"O Golovko","year":"2014","unstructured":"Golovko O, Kumar V, Fedorova G, Randak T, Grabic R (2014) Seasonal changes in antibiotics, antidepressants\/psychiatric drugs, antihistamines and lipid regulators in a wastewater treatment plant. Chemosphere 111:418\u2013426. \n                    https:\/\/doi.org\/10.1016\/j.chemosphere.2014.03.132","journal-title":"Chemosphere"},{"key":"3834_CR23","doi-asserted-by":"crossref","unstructured":"Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DGJ (2008) Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 42(15):5807\u20135813","DOI":"10.1021\/es8005173"},{"issue":"23","key":"3834_CR24","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1080\/10643389.2015.1061873","volume":"45","author":"J Guo","year":"2015","unstructured":"Guo J, Boxall ABA, Selby K (2015) Do pharmaceuticals pose a threat to primary producers? Crit Rev Environ Sci Technol 45(23):2565\u20132610. \n                    https:\/\/doi.org\/10.1080\/10643389.2015.1061873","journal-title":"Crit Rev Environ Sci Technol"},{"key":"3834_CR25","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/etc.3319","volume":"35","author":"J Guo","year":"2016","unstructured":"Guo J, Sinclair CJ, Selby K, Boxall ABA (2016) Toxicological and ecotoxicological risk-based prioritization of pharmaceuticals in the natural environment. Environ Toxicol Chem 35:1550\u20131559. \n                    https:\/\/doi.org\/10.1002\/etc.3319","journal-title":"Environ Toxicol Chem"},{"issue":"4","key":"3834_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/etc.3302","volume":"35","author":"K Helwig","year":"2013","unstructured":"Helwig K, Hunter C, McNaughtan M, Roberts J, Pahl O (2013) Ranking prescribed pharmaceuticals in terms of environmental risk: inclusion of hospital data and the importance of regular review. Environ Toxicol Chem 35(4):1043\u20131050. \n                    https:\/\/doi.org\/10.1002\/etc.3302","journal-title":"Environ Toxicol Chem"},{"key":"3834_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ocecoaman.2016.04.013","volume":"127","author":"Z Hoyett","year":"2016","unstructured":"Hoyett Z, Owens MA, Clark CJ, Abazinge M (2016) A comparative evaluation of environmental risk assessment strategies for pharmaceuticals and personal care products. Ocean Coast Manag 127:74\u201380. \n                    https:\/\/doi.org\/10.1016\/j.ocecoaman.2016.04.013","journal-title":"Ocean Coast Manag"},{"key":"3834_CR28","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1080\/714044797","volume":"9","author":"DB Huggett","year":"2003","unstructured":"Huggett DB, Cook JC, Ericson JF, Williams RT (2003) A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum Ecol Risk Assess 9:1789\u20131799. \n                    https:\/\/doi.org\/10.1080\/714044797","journal-title":"Hum Ecol Risk Assess"},{"key":"3834_CR29","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1021\/es3030148","volume":"47","author":"SR Hughes","year":"2013","unstructured":"Hughes SR, Kay P, Brown LE (2013) Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environ Sci Technol 47:661\u2013677. \n                    https:\/\/doi.org\/10.1021\/es3030148","journal-title":"Environ Sci Technol"},{"key":"3834_CR30","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.scitotenv.2017.05.039","volume":"599\u2013600","author":"AC Johnson","year":"2017","unstructured":"Johnson AC, Donnachie RL, Sumpter JP, J\u00fcrgens MD, Moeckel C, Pereira MG (2017) An alternative approach to risk rank chemicals on the threat they pose to the aquatic environment. Sci Total Environ 599\u2013600:1372\u20131381. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2017.05.039","journal-title":"Sci Total Environ"},{"key":"3834_CR31","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1016\/j.watres.2008.04.026","volume":"42","author":"B Kasprzyk-Hordern","year":"2008","unstructured":"Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ (2008) The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 42:3498\u20133518. \n                    https:\/\/doi.org\/10.1016\/j.watres.2008.04.026","journal-title":"Water Res"},{"key":"3834_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.watres.2008.10.047","volume":"43","author":"B Kasprzyk-Hordern","year":"2009","unstructured":"Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ (2009) The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 43:363\u2013380. \n                    https:\/\/doi.org\/10.1016\/j.watres.2008.10.047","journal-title":"Water Res"},{"key":"3834_CR33","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.envpol.2016.10.087","volume":"220","author":"P Kay","year":"2016","unstructured":"Kay P, Hughes SR, Ault JR, Ashcroft AE, Brown LE (2016) Widespread, routine occurrence of pharmaceuticals in sewage effluent, combined sewer overflows and receiving waters. Environ Pollut 220:1447\u20131455. \n                    https:\/\/doi.org\/10.1016\/j.envpol.2016.10.087","journal-title":"Environ Pollut"},{"key":"3834_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.scitotenv.2007.09.008","volume":"389","author":"MS Kostich","year":"2008","unstructured":"Kostich MS, Lazorchak JM (2008) Risks to aquatic organisms posed by human pharmaceutical use. Sci Total Environ 389:329\u2013339. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2007.09.008","journal-title":"Sci Total Environ"},{"issue":"1656","key":"3834_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1098\/rstb.2013.0587","volume":"369","author":"A K\u00fcster","year":"2014","unstructured":"K\u00fcster A, Adler N (2014) Pharmaceuticals in the environment: scientific evidence of risks and its regulation. Philos Trans R Soc Lond Ser B Biol Sci 369(1656):1\u20138. \n                    https:\/\/doi.org\/10.1098\/rstb.2013.0587","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"1656","key":"3834_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1098\/rstb.2014.0022","volume":"369","author":"CA LaLone","year":"2014","unstructured":"LaLone CA, Berninger JP, Villeneuve DL, Ankley GT (2014) Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms. Philos Trans R Soc Lond Ser B Biol Sci 369(1656):1\u201310. \n                    https:\/\/doi.org\/10.1098\/rstb.2014.0022","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"12","key":"3834_CR37","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1021\/es0627693","volume":"41","author":"J Linert","year":"2007","unstructured":"Linert J, G\u00fcdel K, Escher BI (2007) Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ Sci Technol 41(12):4471\u20134478. \n                    https:\/\/doi.org\/10.1021\/es0627693","journal-title":"Environ Sci Technol"},{"key":"3834_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.scitotenv.2016.03.023","volume":"557","author":"F Mansour","year":"2016","unstructured":"Mansour F, Al-Hindi M, Saad W, Salam D (2016) Environmental risk analysis and prioritization of pharmaceuticals in a developing world context. Sci Total Environ 557:31\u201343. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2016.03.023","journal-title":"Sci Total Environ"},{"issue":"11","key":"3834_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/w8110542","volume":"8","author":"A Mavragani","year":"2016","unstructured":"Mavragani A, Sypsa K, Sampri A, Tsagarakis K (2016) Quantifying the UK online interest in substances of the EU watchlist for water monitoring: diclofenac, estradiol, and the macrolide antibiotics. Water 8(11):1\u201321. \n                    https:\/\/doi.org\/10.3390\/w8110542","journal-title":"Water"},{"key":"3834_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.envres.2015.02.016","volume":"138","author":"R Moreno-Gonz\u00e1lez","year":"2015","unstructured":"Moreno-Gonz\u00e1lez R, Rodriguez-Mozaz S, Gros M, Barcel\u00f3 D, Le\u00f3n VM (2015) Seasonal distribution of pharmaceuticals in marine water and sediment from a Mediterranean coastal lagoon (SE Spain). Environ Res 138:326\u2013344. \n                    https:\/\/doi.org\/10.1016\/j.envres.2015.02.016","journal-title":"Environ Res"},{"key":"3834_CR41","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.scitotenv.2016.09.180","volume":"575","author":"N Nakada","year":"2017","unstructured":"Nakada N, Hanamoto S, J\u00fcrgens MD, Johnson AC, Bowes MJ, Tanaka H (2017) Assessing the population equivalent and performance of wastewater treatment through the ratios of pharmaceuticals and personal care products present in a river basin: application to the River Thames basin, UK. Sci Total Environ 575:1100\u20131108. \n                    https:\/\/doi.org\/10.1016\/J.SCITOTENV.2016.09.180","journal-title":"Sci Total Environ"},{"key":"3834_CR42","unstructured":"NHS (2014) GP practice prescribing presentation-level data. Available from: http:\/\/content.digital.nhs.uk"},{"key":"3834_CR43","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.scitotenv.2012.10.046","volume":"442","author":"M Oosterhuis","year":"2013","unstructured":"Oosterhuis M, Sacher F, ter Laak TL (2013) Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data. Sci Total Environ 442:380\u2013388. \n                    https:\/\/doi.org\/10.1016\/J.scitotenv.2012.10.046","journal-title":"Sci Total Environ"},{"key":"3834_CR44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jenvman.2013.06.035","volume":"129","author":"S Ortiz de Garc\u00eda","year":"2013","unstructured":"Ortiz de Garc\u00eda S, Pinto GP, Garc\u00eda-Encina PA, Mata RI (2013) Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case. J Environ Manag 129:384\u2013397. \n                    https:\/\/doi.org\/10.1016\/j.jenvman.2013.06.035","journal-title":"J Environ Manag"},{"key":"3834_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.scitotenv.2016.08.089","volume":"573","author":"P Pa\u00edga","year":"2016","unstructured":"Pa\u00edga P, Santos LHMLM, Ramos S, Jorge S, Silva JG, Delerue-Matos C (2016) Presence of pharmaceuticals in the Lis River (Portugal): sources, fate and seasonal variation. Sci Total Environ 573:164\u2013177. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2016.08.089","journal-title":"Sci Total Environ"},{"key":"3834_CR46","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1016\/j.scitotenv.2010.09.026","volume":"408","author":"A Pal","year":"2010","unstructured":"Pal A, Gin KYH, Lin AYC, Reinhard M (2010) Impacts of emerging organic contaminants on freshwater resources: review of recent occurrences, sources, fate and effects. Sci Total Environ 408:6062\u20136069. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2010.09.026","journal-title":"Sci Total Environ"},{"key":"3834_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.scitotenv.2017.06.022","volume":"603","author":"AMPT Pereira","year":"2017","unstructured":"Pereira AMPT, Silva LJG, Lino CM, Meisel LM, Pena A (2017) A critical evaluation of different parameters for estimating pharmaceutical exposure seeking an improved environmental risk assessment. Sci Total Environ 603:226\u2013236. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2017.06.022","journal-title":"Sci Total Environ"},{"key":"3834_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.scitotenv.2005.04.031","volume":"356","author":"PH Roberts","year":"2006","unstructured":"Roberts PH, Thomas KV (2006) The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 356:143\u2013153. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2005.04.031","journal-title":"Sci Total Environ"},{"issue":"1","key":"3834_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00244-013-9880-x","volume":"65","author":"C Rodr\u00edgues-Navas","year":"2013","unstructured":"Rodr\u00edgues-Navas C, Bj\u00f6rklund E, Bak SA, Hansen M, Krogh KA, Maya F, Forteza R, Cerd\u00e0 V (2013) Pollution pathways of pharmaceutical residues in the aquatic environment on the Island of Mallorca, Spain. Arch Environ Contam Toxicol 65(1):56\u201366. \n                    https:\/\/doi.org\/10.1007\/s00244-013-9880-x","journal-title":"Arch Environ Contam Toxicol"},{"issue":"1","key":"3834_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yrtph.2006.01.012","volume":"45","author":"D Roode de","year":"2006","unstructured":"de Roode D, Hoekzema C, de Vries-Buitenweg S, van de Waart B, van der Hoeven J (2006) QSARs in ecotoxicological risk assessment. Regul Toxicol Pharmacol 45(1):24\u201335. \n                    https:\/\/doi.org\/10.1016\/j.yrtph.2006.01.012","journal-title":"Regul Toxicol Pharmacol"},{"key":"3834_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.scitotenv.2012.01.039","volume":"421\u2013422","author":"V Roos","year":"2012","unstructured":"Roos V, Gunnarsson L, Fick J, Larsson DGJ, Rud\u00e9n C (2012) Prioritising pharmaceuticals for environmental risk assessment: towards adequate and feasible first-tier selection. Sci Total Environ 421\u2013422:102\u2013110. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2012.01.039","journal-title":"Sci Total Environ"},{"key":"3834_CR52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.toxlet.2009.02.003","volume":"187","author":"H Sanderson","year":"2009","unstructured":"Sanderson H, Thomsen M (2009) Comparative analysis of pharmaceuticals versus industrial chemicals acute aquatic toxicity classification according to the United Nations classification system for chemicals. Assessment of the (Q)SAR predictability of pharmaceuticals acute aquatic toxicity. Toxicol Lett 187:84\u201393. \n                    https:\/\/doi.org\/10.1016\/j.toxlet.2009.02.003","journal-title":"Toxicol Lett"},{"key":"3834_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yrtph.2003.12.006","volume":"39","author":"H Sanderson","year":"2004","unstructured":"Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR (2004) Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharmacol 39:158\u2013183. \n                    https:\/\/doi.org\/10.1016\/j.yrtph.2003.12.006","journal-title":"Regul Toxicol Pharmacol"},{"key":"3834_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.envint.2016.08.008","volume":"95","author":"A Sangion","year":"2016","unstructured":"Sangion A, Gramatica P (2016a) Hazard of pharmaceuticals for aquatic environment: prioritization by structural approaches and prediction of ecotoxicity. Environ Int 95:131\u2013143. \n                    https:\/\/doi.org\/10.1016\/j.envint.2016.08.008","journal-title":"Environ Int"},{"key":"3834_CR55","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.envres.2016.02.021","volume":"147","author":"A Sangion","year":"2016","unstructured":"Sangion A, Gramatica P (2016b) PBT assessment and prioritisation of contaminants of emerging concern: pharmaceuticals. Environ Res 147:297\u2013306. \n                    https:\/\/doi.org\/10.1016\/j.envres.2016.02.021","journal-title":"Environ Res"},{"key":"3834_CR56","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.scitotenv.2013.04.077","volume":"461\u2013462","author":"LH Santos","year":"2013","unstructured":"Santos LH, Gros M, Rodriguez-Mozaz S, Delerue-Matos C, Pena A, Barcel\u00f3 D, Montenegro MC (2013) Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci Total Environ 461\u2013462:302\u2013316. \n                    https:\/\/doi.org\/10.1016\/J.SCITOTENV.2013.04.077","journal-title":"Sci Total Environ"},{"key":"3834_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.yrtph.2011.08.006","volume":"61","author":"R Schrieber","year":"2011","unstructured":"Schrieber R, Gundel U, Franz S, Kuster A, Rechenberg B, Attenburger R (2011) Using the fish plasma model for comparative hazard identification for pharmaceuticals in the environment by extrapolation from human therapeutic data. Regul Toxicol Pharmacol 61:261\u2013275. \n                    https:\/\/doi.org\/10.1016\/J.YRTPH.2011.08.006","journal-title":"Regul Toxicol Pharmacol"},{"key":"3834_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.envpol.2014.12.002","volume":"197","author":"LJG Silva","year":"2015","unstructured":"Silva LJG, Pereira AMPT, Meisel LM, Lino CM, Pena A (2015) Reviewing the serotonin reuptake inhibitors (SSRIs) footprint in the aquatic biota: uptake, bioaccumulation and ecotoxicology. Environ Pollut 197:127\u2013143. \n                    https:\/\/doi.org\/10.1016\/j.envpol.2014.12.002","journal-title":"Environ Pollut"},{"key":"3834_CR59","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/etc.3260","volume":"35","author":"J Vestel","year":"2016","unstructured":"Vestel J, Caldwell DJ, Constantine L, D\u2019Aco VJ, Davidson T, Dolan DG, Millard SP, Murray-Smith R, Parke NJ, Ryan JJ, Straub JO, Wilson P (2016) Use of acute and chronic ecotoxicity data in environmental risk assessment of pharmaceuticals. Environ Toxicol Chem 35:1201\u20131212. \n                    https:\/\/doi.org\/10.1002\/etc.3260","journal-title":"Environ Toxicol Chem"}],"container-title":["Environmental Science and Pollution Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11356-018-3834-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-018-3834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-018-3834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T19:15:55Z","timestamp":1575400555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11356-018-3834-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["3834"],"URL":"https:\/\/doi.org\/10.1007\/s11356-018-3834-9","relation":{},"ISSN":["0944-1344","1614-7499"],"issn-type":[{"value":"0944-1344","type":"print"},{"value":"1614-7499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]},"assertion":[{"value":"10 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}